Cargando…

Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises group of small vessel vasculitides, including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). In 2022, the American College of Rheumatolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyo, Jung Yoon, Lee, Lucy Eunju, Park, Yong-Beom, Lee, Sang-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826961/
https://www.ncbi.nlm.nih.gov/pubmed/36579374
http://dx.doi.org/10.3349/ymj.2022.0435
_version_ 1784866974135746560
author Pyo, Jung Yoon
Lee, Lucy Eunju
Park, Yong-Beom
Lee, Sang-Won
author_facet Pyo, Jung Yoon
Lee, Lucy Eunju
Park, Yong-Beom
Lee, Sang-Won
author_sort Pyo, Jung Yoon
collection PubMed
description Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises group of small vessel vasculitides, including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). In 2022, the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) jointly proposed new classification criteria for AAV (the 2022 ACR/EULAR criteria). In this review, we briefly summarize the 2022 ACR/EULAR criteria for GPA, MPA, and EGPA, and introduce our clinical experience with applying them to patients who were previously diagnosed with AAV based on three criteria: firstly, the classification criteria for GPA and EGPA proposed by the ACR in 1990; secondly, the algorithm for the classification of AAV and polyarteritis nodosa proposed by the European Medicines Agency algorithm in 2007 (the 2007 EMA algorithm); and thirdly, the revised International Chapel Hill Consensus Conference nomenclature of vasculitides in 2012 (the 2012 CHCC definitions). We found that concordance rate was highest in patients with MPA (96.6%), followed by those with EGPA (86.3%) and GPA (73.8%). In addition, compared to previous criteria, we noted several issues of the undervalued or overvalued items in the 2022 ACR/EULAR criteria for classifying AAV and provided several suggestions. To increase the diagnostic accuracy and reduce the discordance rate among the new and previous criteria for AAV, we suggest that the previous criteria should be considered together with the 2022 ACR/EULAR criteria when applying the classification criteria for AAV to patients suspected of AAV.
format Online
Article
Text
id pubmed-9826961
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Yonsei University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-98269612023-01-20 Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria Pyo, Jung Yoon Lee, Lucy Eunju Park, Yong-Beom Lee, Sang-Won Yonsei Med J Review Article Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises group of small vessel vasculitides, including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). In 2022, the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) jointly proposed new classification criteria for AAV (the 2022 ACR/EULAR criteria). In this review, we briefly summarize the 2022 ACR/EULAR criteria for GPA, MPA, and EGPA, and introduce our clinical experience with applying them to patients who were previously diagnosed with AAV based on three criteria: firstly, the classification criteria for GPA and EGPA proposed by the ACR in 1990; secondly, the algorithm for the classification of AAV and polyarteritis nodosa proposed by the European Medicines Agency algorithm in 2007 (the 2007 EMA algorithm); and thirdly, the revised International Chapel Hill Consensus Conference nomenclature of vasculitides in 2012 (the 2012 CHCC definitions). We found that concordance rate was highest in patients with MPA (96.6%), followed by those with EGPA (86.3%) and GPA (73.8%). In addition, compared to previous criteria, we noted several issues of the undervalued or overvalued items in the 2022 ACR/EULAR criteria for classifying AAV and provided several suggestions. To increase the diagnostic accuracy and reduce the discordance rate among the new and previous criteria for AAV, we suggest that the previous criteria should be considered together with the 2022 ACR/EULAR criteria when applying the classification criteria for AAV to patients suspected of AAV. Yonsei University College of Medicine 2023-01 2022-12-01 /pmc/articles/PMC9826961/ /pubmed/36579374 http://dx.doi.org/10.3349/ymj.2022.0435 Text en © Copyright: Yonsei University College of Medicine 2023 https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Pyo, Jung Yoon
Lee, Lucy Eunju
Park, Yong-Beom
Lee, Sang-Won
Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria
title Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria
title_full Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria
title_fullStr Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria
title_full_unstemmed Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria
title_short Comparison of the 2022 ACR/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria
title_sort comparison of the 2022 acr/eular classification criteria for antineutrophil cytoplasmic antibody-associated vasculitis with previous criteria
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826961/
https://www.ncbi.nlm.nih.gov/pubmed/36579374
http://dx.doi.org/10.3349/ymj.2022.0435
work_keys_str_mv AT pyojungyoon comparisonofthe2022acreularclassificationcriteriaforantineutrophilcytoplasmicantibodyassociatedvasculitiswithpreviouscriteria
AT leelucyeunju comparisonofthe2022acreularclassificationcriteriaforantineutrophilcytoplasmicantibodyassociatedvasculitiswithpreviouscriteria
AT parkyongbeom comparisonofthe2022acreularclassificationcriteriaforantineutrophilcytoplasmicantibodyassociatedvasculitiswithpreviouscriteria
AT leesangwon comparisonofthe2022acreularclassificationcriteriaforantineutrophilcytoplasmicantibodyassociatedvasculitiswithpreviouscriteria